or
forgot password
  • cancer clinical trials in des moines, IA

  • Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Iowa Oncology Research Association CCOP

    Trial Locations
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    John Stoddard Cancer Center at Iowa Methodist Medical Center

    Trial Locations
    John Stoddard Cancer Center at Iowa Methodist Medical Center
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Colorectal Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Iowa Methodist Medical Center
    Des Moines, Iowa 50309
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer
    Iowa Methodist Medical Center

    Trial Locations
    Iowa Methodist Medical Center
    Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    John Stoddard Cancer Center at Iowa Lutheran Hospital

    Trial Locations
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Raymond Blank Children's Hospital
    Des Moines, Iowa 50309
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Iowa Methodist Medical Center

    Trial Locations
    Iowa Methodist Medical Center
    Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    CCOP - Iowa Oncology Research Association

    Trial Locations
    CCOP - Iowa Oncology Research Association
    John Stoddard Cancer Center at Iowa Methodist Medical Center
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Breast Cancer
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Iowa Lutheran Hospital

    Trial Locations
    Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma